These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1101766)

  • 21. Failure of anti-Fasciola antisera to induce antibody-dependent, eosinophil-mediated killing of Schistosoma mansoni schistosomula.
    Hillyer GV; Richardson BA; Butterworth AE
    J Parasitol; 1987 Aug; 73(4):774-7. PubMed ID: 3114465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of a partially purified Fasciola gigantica worm antigen in the serological diagnosis of human fascioliasis in Egypt.
    Mansour NS; Youssef FG; Mikhail EM; Boctor FN
    Am J Trop Med Hyg; 1983 May; 32(3):550-4. PubMed ID: 6305221
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Can we vaccinate against schistosomes? An update five years later.
    Hillyer GV
    Bol Asoc Med P R; 1981 Apr; 73(4):150-61. PubMed ID: 6946782
    [No Abstract]   [Full Text] [Related]  

  • 24. The antigens of Paragonimus westermani, Schistosoma mansoni, and Fasciola hepatica adult worms. Evidence for the presence of cross-reactive antigens and for cross-protection to Schistosoma mansoni infection using antigens of Paragonimus westermani.
    Hillyer GV; Serrano AE
    Am J Trop Med Hyg; 1983 Mar; 32(2):350-8. PubMed ID: 6404188
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Solubilization of antigens of Fasciola hepatica which react with antibodies to Schistosoma mansoni.
    Hillyer GV; Pelley RP; del Llano de Diaz A
    J Parasitol; 1979 Feb; 65(1):55-60. PubMed ID: 448600
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Further studies on resistance to Fasciola hepatica and Echinostoma revolutum in mice infected with Schistosoma sp.
    Christensen NO; Nydal R; Frandsen F; Sirag SB; Nansen P
    Z Parasitenkd; 1981; 65(3):293-8. PubMed ID: 7314810
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The defined antigen substrate spheres (DASS) system and some of its applications.
    Capel PJ
    Ann N Y Acad Sci; 1975 Jun; 254():108-18. PubMed ID: 241283
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of excretory/secretory Fasciola (Fhes) antigen in diagnosis of human fascioliasis.
    Haseeb AN; el-Shazly AM; Arafa MA; Morsy AT
    J Egypt Soc Parasitol; 2003 Apr; 33(1):123-38. PubMed ID: 12739806
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of Two FhSAP2 Recombinant-Based Assays for Immunodiagnosis of Human Chronic Fascioliasis.
    Shin SH; Hsu A; Chastain HM; Cruz LA; Elder ES; Sapp SG; McAuliffe I; Espino AM; Handali S
    Am J Trop Med Hyg; 2016 Oct; 95(4):852-855. PubMed ID: 27549636
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isolation and partial characterization of shared antigens of Biomphalaria glabrata and Schistosoma mansoni and their evaluation by the ELISA and the EITB.
    Rivera-Marrero CA; Hillyer GV
    J Parasitol; 1985 Oct; 71(5):547-55. PubMed ID: 3932633
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Partial purification of fasciola hepatica antigen for the immunodiagnosis of fascioliasis in rats.
    Hillyer GV; Santiago de Weil N
    J Parasitol; 1977 Jun; 63(3):430-3. PubMed ID: 864560
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaccination against schistosomiasis and fascioliasis with the new recombinant antigen Sm14: potential basis of a multi-valent anti-helminth vaccine?
    Tendler M; Vilar MM; Brito CA; Freire NM; Katz N; Simpson A
    Mem Inst Oswaldo Cruz; 1995; 90(2):255-6. PubMed ID: 8531667
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Two specific aspects of fluorescent labeling of schistosoma mansoni on frozen sections from Trichinosis and bilharziasis].
    Niel G; Richard-Lenoble D; Gentilini M
    Bull Soc Pathol Exot Filiales; 1976; 69(2):151-6. PubMed ID: 797479
    [No Abstract]   [Full Text] [Related]  

  • 34. [Immunodiagnostic tests for bilharziasis. I. Schistosome antigen characterization and their cross reactions (author's transl)].
    Oelerich S; Umaly RC; Lederer I
    Tropenmed Parasitol; 1974 Sep; 25(3):318-26. PubMed ID: 4610932
    [No Abstract]   [Full Text] [Related]  

  • 35. Successful vaccination against murine Schistosoma mansoni infection with a purified 12 Kd Fasciola hepatica cross-reactive antigen.
    Hillyer GV; García Rosa MI; Alicea H; Hernandez A
    Am J Trop Med Hyg; 1988 Jan; 38(1):103-10. PubMed ID: 3124643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The complement-fixation test in bilharziasis. I. The value of different extracts of Schistosoma mansoni and Fasciola hepatica worms as antigens.
    ELIAKIM M; DAVIES AM
    Parasitology; 1954 Nov; 44(3-4):407-13. PubMed ID: 13214915
    [No Abstract]   [Full Text] [Related]  

  • 37. [Comparative sensitivity of I. F. A. T. using adult Schistosoma antigen and E. L. I. S. A. with ovular antigen in the immunodiagnosis of schistosomiasis (author's transl)].
    Bouilhac M; Le Bras J; Payet M; Savel J; Coulaud JP
    Bull Soc Pathol Exot Filiales; 1981; 74(6):668-75. PubMed ID: 7044585
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Schistosoma mansoni surface glycoprotein cross-reactive with a T1 antigen of Fasciola hepatica.
    Aronstein WS; Dalton JP; Strand M
    Am J Trop Med Hyg; 1985 Sep; 34(5):889-97. PubMed ID: 4037179
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Standardization of FIAXtm for schistosomiasis using crude cercarial and adult worm antigens.
    Slemenda SB; Hitchings M; Maddison SE
    J Parasitol; 1980 Dec; 66(6):893-7. PubMed ID: 7012295
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Specificity of crude and purified Fasciola antigens in immunodiagnosis of human fascioliasis.
    Khalil HM; Abdel TM; Maklad MK; Abdallah HM; Fahmy IA; el Zayyat EA
    J Egypt Soc Parasitol; 1990 Jun; 20(1):87-94. PubMed ID: 1692074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.